Antihemophilic Factor (Recombinant) (Xyntha) and Dynacirc
Determining the interaction of Antihemophilic Factor (Recombinant) (Xyntha) and Dynacirc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: isradipine
Brand name: Dynacirc, Dynacirc CR
Synonyms: DynaCirc
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Xyntha)-Dynacirc CR
- Antihemophilic Factor (Recombinant) (Xyntha)-Dynapen
- Antihemophilic Factor (Recombinant) (Xyntha)-Dyphylline
- Antihemophilic Factor (Recombinant) (Xyntha)-Dyphylline and guaifenesin
- Antihemophilic Factor (Recombinant) (Xyntha)-Dyphylline and Guaifenesin Liquid
- Antihemophilic Factor (Recombinant) (Xyntha)-Dyphylline and Guaifenesin Tablets
- Dynacirc-Antihemophilic factor (recombinant) pegylated-aucl Intravenous
- Dynacirc-Antihemophilic factor (recombinant) porcine sequence Intravenous
- Dynacirc-Antihemophilic factor human
- Dynacirc-Antihemophilic factor Intravenous, Injection
- Dynacirc-Antihemophilic factor recombinant
- Dynacirc-Antihemophilic factor viii and von willebrand factor Intravenous